Fundz

Newleaf Symbiotics Closes $45M Series D Round, Continues Growth Trajectory

PRIVATEDec 19, 2023

Amount Raised

$45 Million

Round Type

Series D

St. LouisAgriculture and FarmingBiotechnology Research

Investors

Leaps By BayerS2 G VenturesOtter Capital Partners LPGullspång Re:

Description

NewLeaf Symbiotics, global leader and pioneer of pink-pigmented facultative methylotrophs (PPFMs), announces the fully funded close of its series D financing round, totaling $45 million. This round was led by new investor Gullspång Re:food and followed by Otter Capital Partners LP, S2G Ventures, Leaps by Bayer and others.

Who else raised in Agriculture and Farming and Biotechnology Research around the same time

Companies in the same sectors as NewLeaf Symbiotics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Monomer Bio raised $5.6M (Funding Round) on February 2, 2024.
  • NeoPhore Ltd raised $12M (Series B) on February 1, 2024.
  • Chamberlain Coffee raised $4.6M on February 1, 2024.
  • LimmaTech Biologics raised $40M (Series A) on February 1, 2024.
  • Aurum Biosciences raised $925K (Seed) on January 31, 2024.
  • Cryomass Technologies raised $6M (Debt Financing) on January 30, 2024.

Who to call at NewLeaf Symbiotics, Inc., and when

A new round usually means NewLeaf Symbiotics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day NewLeaf Symbiotics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NewLeaf Symbiotics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at NewLeaf Symbiotics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

NewLeaf Symbiotics, Inc.

Location

BRDG PARK

St. Louis, Missouri, United States

About

NewLeaf Symbiotics is the industry’s undisputed Ag Biotech leader and pioneer of PPFM technology. The proud Champions of Pink Performance, NewLeaf works to harness pink-pigmented facultative methylotrophs – PPFMs – into actionable solutions to challenges around yield, crop protection, nutrient use efficiency and methane mitigation, with the intent of helping farmers do more with less as they work to feed a growing population.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NewLeaf Symbiotics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsDavid F., Executive Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for NewLeaf Symbiotics, Inc.'s next move

See what Strategic adds

NewLeaf Symbiotics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.